EUVIMEDOpdag EUVIMED
Crossref

Assessing the impact of different solvents in the bacterial reverse mutation test

Satyam N Patel iD, Chetan K Kajavadara iD, Rushikesh M Shukla, Darshan T Valani, Laxit K Bhatt iD, Rajesh Sundar, Mukul R Jain iD

Environmental and Molecular Mutagenesis · 2025

DOI: 10.1002/em.22649 ↗

At a glance

Journal article in Environmental and Molecular Mutagenesis, 2025. Written by Satyam N Patel and 6 co-authors. Institution: Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, Gujarat, India. Major MEDLINE topics: Solvents, Salmonella typhimurium, Escherichia coli, Mutagens. Cited 2 times so far (Crossref); 11 references. Funded by: Zydus Lifesciences Limited, Ahmedabad, India.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The bacterial reverse mutation test is essential for identifying the mutagenic potential of chemicals. The solubility of the test substance is vital for achieving the recommended assay concentration. Preferred solvents like dimethyl sulfoxide and water are chosen for their compatibility and historical data. Selecting a compatible solvent with Salmonella typhimurium and Escherichia coli WP2 uvrA strains, considering a maximum cytotoxic concentration or the limit of 5 mg/plate, can be challenging. This study assessed various solvents, including N,N‐dimethylformamide, acetone, acetonitrile, ethyl acetate, 95% ethanol, diethylene glycol monomethyl ether, methanol, P‐dioxane, tetrahydrofuran, and dimethylacetamide, as alternative solvents in the AMES test. Results showed all solvents, except tetrahydrofuran, were compatible at concentrations up to 100 μL/plate or more, as they did not inhibit S9 enzymes, bacterial growth, or alter bacterial revertant colony counts, making them suitable for the bacterial reverse mutation test.

Subjects

MeSH terms (MEDLINE)

SolventsSalmonella typhimuriumEscherichia coliMutagensMutagenicity TestsMutation

Author keywords

Escherichia coli Wp2 uvrASalmonella typhimuriumcompatibilitycytotoxicitysolvents

Substances

SolventsMutagens

Authors and institutions

  • Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, Gujarat, India.

ORCID profiles: Satyam N Patel, Chetan K Kajavadara, Laxit K Bhatt, Mukul R Jain

Funding

  • Zydus Lifesciences Limited, Ahmedabad, India

Cite

APA

Patel, S. N., Kajavadara, C. K., Shukla, R. M., Valani, D. T., Bhatt, L. K., Sundar, R., & Jain, M. R. (2025). Assessing the impact of different solvents in the bacterial reverse mutation test. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.22649

Vancouver

Patel SN, Kajavadara CK, Shukla RM, Valani DT, Bhatt LK, Sundar R, et al. Assessing the impact of different solvents in the bacterial reverse mutation test. Environmental and Molecular Mutagenesis. 2025. doi:10.1002/em.22649

BibTeX
@article{Patel2025,
  author = {Patel, Satyam N and Kajavadara, Chetan K and Shukla, Rushikesh M and Valani, Darshan T and Bhatt, Laxit K and Sundar, Rajesh and Jain, Mukul R},
  title = {Assessing the impact of different solvents in the bacterial reverse mutation test},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2025},
  doi = {10.1002/em.22649}
}
Start for free →